Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Exogen Registry Data "Minimally Acceptable" For SAFHS Medicare Coverage

This article was originally published in The Gray Sheet

Executive Summary

Exogen's registry data and several well-controlled foreign studies were sufficient for the Health Care Financing Administration to approve the firm's request for national Medicare coverage for the Sonic Accelerated Fracture Healing System (SAFHS).

You may also be interested in...

Exogen Avoids Lengthy MCAC Process In HCFA Coverage Review

The Health Care Financing Administration plans to develop a national Medicare coverage decision for Exogen's Sonic Accelerated Fracture Healing System (SAFHS) without bringing the issue before the Medicare Coverage Advisory Committee, agency staffers report.

Smith & Nephew Exogen 2000 Labeling For Non-Union Fracture Approved

Smith & Nephew will employ its 300-person direct sales force to promote an expanded indication for the Exogen 2000 low-intensity pulsed ultrasound device for treatment of non-union bone fractures, a market valued at roughly $110 mil.

Long Hot Summer For Novel Drug Reviews Forecast At US FDA

Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts